Transcription factor 4 ( TCF4 ) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia
In't Hout, Florentien E M, Gerritsen, Mylène, Bullinger, Lars, Van der Reijden, Bert A, Huls, Gerwin, Vellenga, Edo, Jansen, Joop H
Published in Haematologica (Roma) (01.09.2020)
Published in Haematologica (Roma) (01.09.2020)
Get full text
Journal Article
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients
In 't Hout, Florentien E M, Scheele, Thessa N, Westers, Theresia M, Alhan, Canan, Duetz, Carolien, Cremers, Eline M P, Visser-Wisselaar, Heleen A, Verbrugge, Annelies, Chitu, Dana A, Van der Reijden, Bert A, De Graaf, Aniek O, Van de Loosdrecht, Arjan A, Jansen, Joop H
Published in Haematologica (Roma) (10.10.2024)
Published in Haematologica (Roma) (10.10.2024)
Get full text
Journal Article
Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma
In 't Hout, Florentien E M, Haydu, Lauren E, Murali, Rajmohan, Bonenkamp, Johannes J, Thompson, John F, Scolyer, Richard A
Published in Annals of surgery (01.06.2012)
Published in Annals of surgery (01.06.2012)
Get more information
Journal Article
P455: RUNX1 DIRECTLY BINDS AND REGULATES THE TCF4 PROMOTER
Gerritsen, Mylene, In‘t Hout, Florentien E.M., G.H.J.N. Knops, Ruth, Van Der Reijden, Bert A., Martens, Joost H.A., H Jansen, Joop
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisions
in 't Hout, Florentien E M, van der Reijden, Bert A, Monteferrario, Davide, Jansen, Joop H, Huls, Gerwin
Published in Haematologica (Roma) (01.12.2014)
Published in Haematologica (Roma) (01.12.2014)
Get full text
Journal Article